Main Menu

Publications Highlights View all by category

Types of Publications


Journal Articles

Clarke, M. Mackay, A. Ismer, B. Pickles, J.C. Tatevossian, R.G. Newman, S. Bale, T.A. Stoler, I. Izquierdo, E. Temelso, S. Carvalho, D.M. Molinari, V. Burford, A. Howell, L. Virasami, A. Fairchild, A.R. Avery, A. Chalker, J. Kristiansen, M. Haupfear, K. Dalton, J.D. Orisme, W. Wen, J. Hubank, M. Kurian, K.M. Rowe, C. Maybury, M. Crosier, S. Knipstein, J. Schüller, U. Kordes, U. Kram, D.E. Snuderl, M. Bridges, L. Martin, A.J. Doey, L.J. Al-Sarraj, S. Chandler, C. Zebian, B. Cairns, C. Natrajan, R. Boult, J.K. Robinson, S.P. Sill, M. Dunkel, I.J. Gilheeney, S.W. Rosenblum, M.K. Hughes, D. Proszek, P.Z. Macdonald, T.J. Preusser, M. Haberler, C. Slavc, I. Packer, R. Ng, H.-. Caspi, S. Popović, M. Faganel Kotnik, B. Wood, M.D. Baird, L. Davare, M.A. Solomon, D.A. Olsen, T.K. Brandal, P. Farrell, M. Cryan, J.B. Capra, M. Karremann, M. Schittenhelm, J. Schuhmann, M.U. Ebinger, M. Dinjens, W.N. Kerl, K. Hettmer, S. Pietsch, T. Andreiuolo, F. Driever, P.H. Korshunov, A. Hiddingh, L. Worst, B.C. Sturm, D. Zuckermann, M. Witt, O. Bloom, T. Mitchell, C. Miele, E. Colafati, G.S. Diomedi-Camassei, F. Bailey, S. Moore, A.S. Hassall, T.E. Lowis, S.P. Tsoli, M. Cowley, M.J. Ziegler, D.S. Karajannis, M.A. Aquilina, K. Hargrave, D.R. Carceller, F. Marshall, L.V. von Deimling, A. Kramm, C.M. Pfister, S.M. Sahm, F. Baker, S.J. Mastronuzzi, A. Carai, A. Vinci, M. Capper, D. Popov, S. Ellison, D.W. Jacques, T.S. Jones, D.T. Jones, C. (2020). Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. Cancer discovery, Vol.10 (7), pp. 942-963.  show abstract

Zormpas-Petridis, K. Poon, E. Clarke, M. Jerome, N.P. Boult, J.K. Blackledge, M.D. Carceller, F. Koers, A. Barone, G. Pearson, A.D. Moreno, L. Anderson, J. Sebire, N. McHugh, K. Koh, D.-. Chesler, L. Yuan, Y. Robinson, S.P. Jamin, Y. (2020). Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma. Cancer research, Vol.80 (16), pp. 3424-3435.  show abstract

King, D. Li, X.D. Almeida, G.S. Kwok, C. Gravells, P. Harrison, D. Burke, S. Hallsworth, A. Jamin, Y. George, S. Robinson, S.P. Lord, C.J. Poon, E. Yeomanson, D. Chesler, L. Bryant, H.E. (2020). MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. Oncotarget, Vol.11 (23), pp. 2141-2159.  show abstract

Nimalasena, S. Gothard, L. Anbalagan, S. Allen, S. Sinnett, V. Mohammed, K. Kothari, G. Musallam, A. Lucy, C. Yu, S. Nayamundanda, G. Kirby, A. Ross, G. Sawyer, E. Castell, F. Cleator, S. Locke, I. Tait, D. Westbury, C. Wolstenholme, V. Box, C. Robinson, S.P. Yarnold, J. Somaiah, N. (2020). Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial. International journal of radiation oncology, biology, physics, Vol.108 (4), pp. 1019-1029.  show abstract

Poon, E. Liang, T. Jamin, Y. Walz, S. Kwok, C. Hakkert, A. Barker, K. Urban, Z. Thway, K. Zeid, R. Hallsworth, A. Box, G. Ebus, M.E. Licciardello, M.P. Sbirkov, Y. Lazaro, G. Calton, E. Costa, B.M. Valenti, M. De Haven Brandon, A. Webber, H. Tardif, N. Almeida, G.S. Christova, R. Boysen, G. Richards, M.W. Barone, G. Ford, A. Bayliss, R. Clarke, P.A. De Bono, J. Gray, N.S. Blagg, J. Robinson, S.P. Eccles, S.A. Zheleva, D. Bradner, J.E. Molenaar, J. Vivanco, I. Eilers, M. Workman, P. Lin, C.Y. Chesler, L. (2020). Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma. The journal of clinical investigation, Vol.130 (11), pp. 5875-5892.  show abstract

Bernauer, C. Man, Y.K. Chisholm, J.C. Lepicard, E.Y. Robinson, S.P. Shipley, J.M. (2020). Hypoxia and its therapeutic possibilities in paediatric cancers. British journal of cancer, .  show abstract

O'Connor, J.P. Robinson, S.P. Waterton, J.C. (2019). Imaging tumour hypoxia with oxygen-enhanced MRI and BOLD MRI. The british journal of radiology, Vol.92 (1095), pp. 20180642-?.  show abstract

Carreno, G. Boult, J.K. Apps, J. Gonzalez-Meljem, J.M. Haston, S. Guiho, R. Stache, C. Danielson, L.S. Koers, A. Smith, L.M. Virasami, A. Panousopoulos, L. Buchfelder, M. Jacques, T.S. Chesler, L. Robinson, S.P. Martinez-Barbera, J.P. (2019). SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. Endocrine-related cancer, Vol.26 (3), pp. 355-366.  show abstract

Zormpas-Petridis, K. Jerome, N.P. Blackledge, M.D. Carceller, F. Poon, E. Clarke, M. McErlean, C.M. Barone, G. Koers, A. Vaidya, S.J. Marshall, L.V. Pearson, A.D. Moreno, L. Anderson, J. Sebire, N. McHugh, K. Koh, D.-. Yuan, Y. Chesler, L. Robinson, S.P. Jamin, Y. (2019). MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment. Cancer research, Vol.79 (11), pp. 2978-2991.  show abstract

Yogev, O. Almeida, G.S. Barker, K.T. George, S.L. Kwok, C. Campbell, J. Zarowiecki, M. Kleftogiannis, D. Smith, L.M. Hallsworth, A. Berry, P. Möcklinghoff, T. Webber, H.T. Danielson, L.S. Buttery, B. Calton, E.A. da Costa, B.M. Poon, E. Jamin, Y. Lise, S. Veal, G.J. Sebire, N. Robinson, S.P. Anderson, J. Chesler, L. (2019). In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis. Cancer research, Vol.79 (20), pp. 5382-5393.  show abstract

Li, J. Zormpas-Petridis, K. Boult, J.K. Reeves, E.L. Heindl, A. Vinci, M. Lopes, F. Cummings, C. Springer, C.J. Chesler, L. Jones, C. Bamber, J.C. Yuan, Y. Sinkus, R. Jamin, Y. Robinson, S.P. (2019). Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance Elastography. Cancer research, Vol.79 (22), pp. 5874-5883.  show abstract

Baker, L.C. Sikka, A. Price, J.M. Boult, J.K. Lepicard, E.Y. Box, G. Jamin, Y. Spinks, T.J. Kramer-Marek, G. Leach, M.O. Eccles, S.A. Box, C. Robinson, S.P. (2018). Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma. Frontiers in oncology, Vol.8, pp. 271-?.  show abstract

Khan, A.A. Paget, J.T. McLaughlin, M. Kyula, J.N. Wilkinson, M.J. Pencavel, T. Mansfield, D. Roulstone, V. Seth, R. Halle, M. Somaiah, N. Boult, J.K. Robinson, S.P. Pandha, H.S. Vile, R.G. Melcher, A.A. Harris, P.A. Harrington, K.J. (2018). Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Science translational medicine, Vol.10 (425).  show abstract

Vlachogiannis, G. Hedayat, S. Vatsiou, A. Jamin, Y. Fernández-Mateos, J. Khan, K. Lampis, A. Eason, K. Huntingford, I. Burke, R. Rata, M. Koh, D.-. Tunariu, N. Collins, D. Hulkki-Wilson, S. Ragulan, C. Spiteri, I. Moorcraft, S.Y. Chau, I. Rao, S. Watkins, D. Fotiadis, N. Bali, M. Darvish-Damavandi, M. Lote, H. Eltahir, Z. Smyth, E.C. Begum, R. Clarke, P.A. Hahne, J.C. Dowsett, M. de Bono, J. Workman, P. Sadanandam, A. Fassan, M. Sansom, O.J. Eccles, S. Starling, N. Braconi, C. Sottoriva, A. Robinson, S.P. Cunningham, D. Valeri, N. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science (new york, n.y.), Vol.359 (6378), pp. 920-926.  show abstract

Jerome, N.P. Boult, J.K. Orton, M.R. d'Arcy, J.A. Nerurkar, A. Leach, M.O. Koh, D.-. Collins, D.J. Robinson, S.P. (2018). Characterisation of fibrosis in chemically-induced rat mammary carcinomas using multi-modal endogenous contrast MRI on a 1 5T clinical platform. European radiology, Vol.28 (4), pp. 1642-1653.  show abstract

Walker-Samuel, S. Roberts, T.A. Ramasawmy, R. Burrell, J.S. Johnson, S.P. Siow, B.M. Richardson, S. Gonçalves, M.R. Pendse, D. Robinson, S.P. Pedley, R.B. Lythgoe, M.F. (2018). Investigating Low-Velocity Fluid Flow in Tumors with Convection-MRI. Cancer research, Vol.78 (7), pp. 1859-1872.  show abstract

Boult, J.K. Apps, J.R. Hölsken, A. Hutchinson, J.C. Carreno, G. Danielson, L.S. Smith, L.M. Bäuerle, T. Buslei, R. Buchfelder, M. Virasami, A.K. Koers, A. Arthurs, O.J. Jacques, T.S. Chesler, L. Martinez-Barbera, J.P. Robinson, S.P. (2018). Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma. Brain pathology (zurich, switzerland), Vol.28 (4), pp. 475-483.  show abstract

Papaevangelou, E. Boult, J.K. Whitley, G.S. Robinson, S.P. Howe, F.A. (2018). Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo. Angiogenesis, Vol.21 (4), pp. 737-749.  show abstract

Al-Saffar, N.M. Troy, H. Wong Te Fong, A.-. Paravati, R. Jackson, L.E. Gowan, S. Boult, J.K. Robinson, S.P. Eccles, S.A. Yap, T.A. Leach, M.O. Chung, Y.-. (2018). Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma. British journal of cancer, Vol.119 (9), pp. 1118-1128.  show abstract

O'Connor, J.P. Aboagye, E.O. Adams, J.E. Aerts, H.J. Barrington, S.F. Beer, A.J. Boellaard, R. Bohndiek, S.E. Brady, M. Brown, G. Buckley, D.L. Chenevert, T.L. Clarke, L.P. Collette, S. Cook, G.J. deSouza, N.M. Dickson, J.C. Dive, C. Evelhoch, J.L. Faivre-Finn, C. Gallagher, F.A. Gilbert, F.J. Gillies, R.J. Goh, V. Griffiths, J.R. Groves, A.M. Halligan, S. Harris, A.L. Hawkes, D.J. Hoekstra, O.S. Huang, E.P. Hutton, B.F. Jackson, E.F. Jayson, G.C. Jones, A. Koh, D.-. Lacombe, D. Lambin, P. Lassau, N. Leach, M.O. Lee, T.-. Leen, E.L. Lewis, J.S. Liu, Y. Lythgoe, M.F. Manoharan, P. Maxwell, R.J. Miles, K.A. Morgan, B. Morris, S. Ng, T. Padhani, A.R. Parker, G.J. Partridge, M. Pathak, A.P. Peet, A.C. Punwani, S. Reynolds, A.R. Robinson, S.P. Shankar, L.K. Sharma, R.A. Soloviev, D. Stroobants, S. Sullivan, D.C. Taylor, S.A. Tofts, P.S. Tozer, G.M. van Herk, M. Walker-Samuel, S. Wason, J. Williams, K.J. Workman, P. Yankeelov, T.E. Brindle, K.M. McShane, L.M. Jackson, A. Waterton, J.C. (2017). Imaging biomarker roadmap for cancer studies. Nature reviews. clinical oncology, Vol.14 (3), pp. 169-186.  show abstract

Panek, R. Welsh, L. Baker, L.C. Schmidt, M.A. Wong, K.H. Riddell, A.M. Koh, D.-. Dunlop, A. Mcquaid, D. d'Arcy, J.A. Bhide, S.A. Harrington, K.J. Nutting, C.M. Hopkinson, G. Richardson, C. Box, C. Eccles, S.A. Leach, M.O. Robinson, S.P. Newbold, K.L. (2017). Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI. Clinical cancer research : an official journal of the american association for cancer research, Vol.23 (15), pp. 4233-4241.  show abstract

Robinson, S.P. Boult, J.K. Vasudev, N.S. Reynolds, A.R. (2017). Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI. Cancer research, Vol.77 (15), pp. 4127-4134.  show abstract

Tucker, E.R. Tall, J.R. Danielson, L.S. Gowan, S. Jamin, Y. Robinson, S.P. Banerji, U. Chesler, L. (2017). Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma. Molecular oncology, Vol.11 (8), pp. 996-1006.  show abstract

Boult, J.K. Box, G. Vinci, M. Perryman, L. Eccles, S.A. Jones, C. Robinson, S.P. (2017). Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI. Neoplasia (new york, n.y.), Vol.19 (9), pp. 684-694.  show abstract

Almeida, G.S. Panek, R. Hallsworth, A. Webber, H. Papaevangelou, E. Boult, J.K. Jamin, Y. Chesler, L. Robinson, S.P. (2017). Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform. British journal of cancer, Vol.117 (6), pp. 791-800.  show abstract

Elyas, E. Papaevangelou, E. Alles, E.J. Erler, J.T. Cox, T.R. Robinson, S.P. Bamber, J.C. (2017). Correlation of Ultrasound Shear Wave Elastography with Pathological Analysis in a Xenografic Tumour Model. Scientific reports, Vol.7 (1), pp. 165-?.  show abstract

Shah, A. Delgado-Goni, T. Casals Galobart, T. Wantuch, S. Jamin, Y. Leach, M.O. Robinson, S.P. Bamber, J. Beloueche-Babari, M. (2017). Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging. Scientific reports, Vol.7 (1), pp. 8215-?.  show abstract

Elyas, E. Grimwood, A. Erler, J.T. Robinson, S.P. Cox, T.R. Woods, D. Clowes, P. De Luca, R. Marinozzi, F. Fromageau, J. Bamber, J.C. (2017). Multi-Channel Optical Coherence Elastography Using Relative and Absolute Shear-Wave Time of Flight. Plos one, Vol.12 (1), pp. e0169664-?.  show abstract

Papaevangelou, E. Whitley, G.S. Johnstone, A.P. Robinson, S.P. Howe, F.A. (2016). Investigating the role of tumour cell derived iNOS on tumour growth and vasculaturein vivousing a tetracycline regulated expression system. International journal of cancer, Vol.138 (11), pp. 2678-2687.

O'Connor, J.P. Boult, J.K. Jamin, Y. Babur, M. Finegan, K.G. Williams, K.J. Little, R.A. Jackson, A. Parker, G.J. Reynolds, A.R. Waterton, J.C. Robinson, S.P. (2016). Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models. Cancer research, Vol.76 (4), pp. 787-795.  show abstract

Jerome, N.P. Boult, J.K. Orton, M.R. d'Arcy, J. Collins, D.J. Leach, M.O. Koh, D.-. Robinson, S.P. (2016). Modulation of renal oxygenation and perfusion in rat kidney monitored by quantitative diffusion and blood oxygen level dependent magnetic resonance imaging on a clinical 1 5T platform. Bmc nephrology, Vol.17 (1), pp. 142-?.  show abstract

Yogev, O. Barker, K. Sikka, A. Almeida, G.S. Hallsworth, A. Smith, L.M. Jamin, Y. Ruddle, R. Koers, A. Webber, H.T. Raynaud, F.I. Popov, S. Jones, C. Petrie, K. Robinson, S.P. Keun, H.C. Chesler, L. (2016). p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance. Cancer research, Vol.76 (10), pp. 3025-3035.  show abstract

Osborne, J.D. Matthews, T.P. McHardy, T. Proisy, N. Cheung, K.-. Lainchbury, M. Brown, N. Walton, M.I. Eve, P.D. Boxall, K.J. Hayes, A. Henley, A.T. Valenti, M.R. De Haven Brandon, A.K. Box, G. Jamin, Y. Robinson, S.P. Westwood, I.M. van Montfort, R.L. Leonard, P.M. Lamers, M.B. Reader, J.C. Aherne, G.W. Raynaud, F.I. Eccles, S.A. Garrett, M.D. Collins, I. (2016). Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737). Journal of medicinal chemistry, Vol.59 (11), pp. 5221-5237.  show abstract

Vinci, M. Molinari, V. Taylor, K. Carvalho, D. Burford, A. Mackay, A. Popov, S. Fofama, M. Fazal-Salom, J. Bjerke, L. Boult, J.K. Pemberton, H. Lord, C.J. Howell, L. Pears, J. Mastronuzzi, A. Carai, A. Marshall, L.V. Zacharoulis, S. Vaidya, S. Mandeville, H.C. Bridges, L.R. Martin, A.J. Al-Sarraj, S. Chandler, C. Robinson, S.P. Olaciregui, N.G. Sunol, M. Mora, J. de Torres, C. Cruz, O. Monje, M. Moore, A.S. Carcaboso, A.M. Jones, C. (2016). HG-99A PATIENT-DERIVED PAEDIATRIC HIGH GRADE GLIOMA AND DIPG CELL CULTURE PANEL RECAPITULATING THE GENOTYPIC AND PHENOTYPIC DIVERSITY OF THE DISEASE. Neuro-oncology, Vol.18 (suppl 3), pp. iii71.3-iii71.

Fofana, M. Boult, J.K. Vinci, M. Molinari, V. Popov, S. Mackay, A. Carcaboso, A.M. Jones, C. Robinson, S.P. (2016). PCM-08IN VIVOMAGNETIC RESONANCE IMAGING IDENTIFIES CLINICAL PHENOTYPES OF PAEDIATRIC GLIOBLASTOMA IN AN ORTHOTOPIC MOUSE XENOGRAFT MODEL. Neuro-oncology, Vol.18 (suppl 3), pp. iii140.4-iii141.

Panek, R. Welsh, L. Dunlop, A. Wong, K.H. Riddell, A.M. Koh, D.-. Schmidt, M.A. Doran, S. Mcquaid, D. Hopkinson, G. Richardson, C. Nutting, C.M. Bhide, S.A. Harrington, K.J. Robinson, S.P. Newbold, K.L. Leach, M.O. (2016). Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T. Journal of magnetic resonance imaging : jmri, Vol.44 (1), pp. 72-80.  show abstract

Vaughan, L. Clarke, P.A. Barker, K. Chanthery, Y. Gustafson, C.W. Tucker, E. Renshaw, J. Raynaud, F. Li, X. Burke, R. Jamin, Y. Robinson, S.P. Pearson, A. Maira, M. Weiss, W.A. Workman, P. Chesler, L. (2016). Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors. Oncotarget, Vol.7 (36), pp. 57525-57544.  show abstract

Guan, J. Tucker, E.R. Wan, H. Chand, D. Danielson, L.S. Ruuth, K. El Wakil, A. Witek, B. Jamin, Y. Umapathy, G. Robinson, S.P. Johnson, T.W. Smeal, T. Martinsson, T. Chesler, L. Palmer, R.H. Hallberg, B. (2016). The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN. Disease models & mechanisms, Vol.9 (9), pp. 941-952.  show abstract

Baker, L.C. Boult, J.K. Thomas, M. Koehler, A. Nayak, T. Tessier, J. Ooi, C.-. Birzele, F. Belousov, A. Zajac, M. Horn, C. LeFave, C. Robinson, S.P. (2016). Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling. British journal of cancer, Vol.115 (6), pp. 691-702.  show abstract

Burrell, J.S. Walker-Samuel, S. Boult, J.K. Baker, L.C. Jamin, Y. Halliday, J. Waterton, J.C. Robinson, S.P. (2016). Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen Ultrasmall Superparamagnetic Iron Oxide MRI. Topics in magnetic resonance imaging : tmri, Vol.25 (5), pp. 237-243.  show abstract

Boult, J.K. Borri, M. Jury, A. Popov, S. Box, G. Perryman, L. Eccles, S.A. Jones, C. Robinson, S.P. (2016). Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging. Nmr in biomedicine, Vol.29 (11), pp. 1608-1617.  show abstract

Jamin, Y. Boult, J.K. Li, J. Popov, S. Garteiser, P. Ulloa, J.L. Cummings, C. Box, G. Eccles, S.A. Jones, C. Waterton, J.C. Bamber, J.C. Sinkus, R. Robinson, S.P. (2015). Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography. Cancer res, Vol.75 (7), pp. 1216-1224.  show abstract

McErlean, C.M. Boult, J.K. Collins, D.J. Leach, M.O. Robinson, S.P. Doran, S.J. (2015). Detecting microvascular changes in the mouse spleen using optical computed tomography. Microvascular research, Vol.101, pp. 96-102.

Dolman, M.E. Poon, E. Ebus, M.E. den Hartog, I.J. van Noesel, C.J. Jamin, Y. Hallsworth, A. Robinson, S.P. Petrie, K. Sparidans, R.W. Kok, R.J. Versteeg, R. Caron, H.N. Chesler, L. Molenaar, J.J. (2015). Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma. Clinical cancer research : an official journal of the american association for cancer research, Vol.21 (22), pp. 5100-5109.  show abstract

Hill, R.M. Kuijper, S. Lindsey, J.C. Petrie, K. Schwalbe, E.C. Barker, K. Boult, J.K. Williamson, D. Ahmad, Z. Hallsworth, A. Ryan, S.L. Poon, E. Robinson, S.P. Ruddle, R. Raynaud, F.I. Howell, L. Kwok, C. Joshi, A. Nicholson, S.L. Crosier, S. Ellison, D.W. Wharton, S.B. Robson, K. Michalski, A. Hargrave, D. Jacques, T.S. Pizer, B. Bailey, S. Swartling, F.J. Weiss, W.A. Chesler, L. Clifford, S.C. (2015). Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease. Cancer cell, Vol.27 (1), pp. 72-84.  show abstract

Doblas, S. Almeida, G.S. Blé, F.-. Garteiser, P. Hoff, B.A. McIntyre, D.J. Wachsmuth, L. Chenevert, T.L. Faber, C. Griffiths, J.R. Jacobs, A.H. Morris, D.M. O'Connor, J.P. Robinson, S.P. Van Beers, B.E. Waterton, J.C. (2015). Apparent diffusion coefficient is highly reproducible on preclinical imaging systems: Evidence from a seven-center multivendor study. Journal of magnetic resonance imaging, Vol.42 (6), pp. 1759-1764.

O'Connor, J.P. Boult, J.K. Jamin, Y. Babur, M. Finegan, K.G. Williams, K.J. Reynolds, A.R. Little, R.A. Jackson, A. Parker, G.J. Waterton, J.C. Robinson, S.P. (2015). Oxygen-enhanced MRI can accurately identify, quantify and map tumour hypoxia in preclinical models. Cancer imaging, Vol.15 (S1).

Haider, M.-. Hunter, K.D. Robinson, S.P. Graham, T.J. Corey, E. Dear, T.N. Hughes, R. Brown, N.J. Holen, I. (2015). Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo. Bone, Vol.81, pp. 581-592.

Papaevangelou, E. Almeida, G.S. Jamin, Y. Robinson, S.P. deSouza, N.M. (2015). Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy. British journal of cancer, Vol.112 (9), pp. 1471-1479.  show abstract

Li, J. Jamin, Y. Boult, J.K. Cummings, C. Waterton, J.C. Ulloa, J. Sinkus, R. Bamber, J.C. Robinson, S.P. (2014). Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography. Br j cancer, Vol.110 (7), pp. 1727-1732.  show abstract

Jamin, Y. Eykyn, T.R. Poon, E. Springer, C.J. Robinson, S.P. (2014). Detection of the prodrug-activating enzyme carboxypeptidase G2 activity with chemical exchange saturation transfer magnetic resonance. Mol imaging biol, Vol.16 (2), pp. 152-157.  show abstract

Graham, T.J. Box, G. Tunariu, N. Crespo, M. Spinks, T.J. Miranda, S. Attard, G. de Bono, J. Eccles, S.A. Davies, F.E. Robinson, S.P. (2014). Preclinical evaluation of imaging biomarkers for prostate cancer bone metastasis and response to cabozantinib. J natl cancer inst, Vol.106 (4), p. dju033.  show abstract

Lin, G. Hill, D.K. Andrejeva, G. Boult, J.K. Troy, H. Fong, A.-. Orton, M.R. Panek, R. Parkes, H.G. Jafar, M. Koh, D.-. Robinson, S.P. Judson, I.R. Griffiths, J.R. Leach, M.O. Eykyn, T.R. Chung, Y.-. (2014). Dichloroacetate induces autophagy in colorectal cancer cells and tumours. Br j cancer, Vol.111 (2), pp. 375-385.  show abstract

Lin, G. Andrejeva, G. Wong Te Fong, A.-. Hill, D.K. Orton, M.R. Parkes, H.G. Koh, D.-. Robinson, S.P. Leach, M.O. Eykyn, T.R. Chung, Y.-. (2014). Reduced Warburg effect in cancer cells undergoing autophagy: steady- state 1H-MRS and real-time hyperpolarized 13C-MRS studies. Plos one, Vol.9 (3), p. e92645.  show abstract

Jamin, Y. Glass, L. Hallsworth, A. George, R. Koh, D.-. Pearson, A.D. Chesler, L. Robinson, S.P. (2014). Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastoma. Plos one, Vol.9 (3), p. e92886.  show abstract

Jamin, Y. Tucker, E.R. Poon, E. Popov, S. Vaughan, L. Boult, J.K. Webber, H. Hallsworth, A. Baker, L.C. Jones, C. Koh, D.-. Pearson, A.D. Chesler, L. Robinson, S.P. (2013). Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma. Radiology, Vol.266 (1), pp. 130-140.  show abstract

Baker, L.C. Boult, J.K. Jamin, Y. Gilmour, L.D. Walker-Samuel, S. Burrell, J.S. Ashcroft, M. Howe, F.A. Griffiths, J.R. Raleigh, J.A. van der Kogel, A.J. Robinson, S.P. (2013). Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation. Int j radiat oncol biol phys, Vol.87 (1), pp. 160-167.  show abstract

Burrell, J.S. Walker-Samuel, S. Baker, L.C. Boult, J.K. Jamin, Y. Halliday, J. Waterton, J.C. Robinson, S.P. (2013). Exploring ΔR(2) * and ΔR(1) as imaging biomarkers of tumor oxygenation. J magn reson imaging, Vol.38 (2), pp. 429-434.  show abstract

Brockmann, M. Poon, E. Berry, T. Carstensen, A. Deubzer, H.E. Rycak, L. Jamin, Y. Thway, K. Robinson, S.P. Roels, F. Witt, O. Fischer, M. Chesler, L. Eilers, M. (2013). Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer cell, Vol.24 (1), pp. 75-89.  show abstract

Price, J.M. Robinson, S.P. Koh, D.M. (2013). Imaging hypoxia in tumours with advanced MRI. Q j nucl med mol imaging, Vol.57 (3), pp. 257-270.  show abstract

Hill, D.K. Jamin, Y. Orton, M.R. Tardif, N. Parkes, H.G. Robinson, S.P. Leach, M.O. Chung, Y.-. Eykyn, T.R. (2013). ¹H NMR and hyperpolarized ¹³C NMR assays of pyruvate-lactate: a comparative study. Nmr biomed, Vol.26 (10), pp. 1321-1325.  show abstract

Eccles, S.A. Aboagye, E.O. Ali, S. Anderson, A.S. Armes, J. Berditchevski, F. Blaydes, J.P. Brennan, K. Brown, N.J. Bryant, H.E. Bundred, N.J. Burchell, J.M. Campbell, A.M. Carroll, J.S. Clarke, R.B. Coles, C.E. Cook, G.J. Cox, A. Curtin, N.J. Dekker, L.V. dos Santos Silva, I. Duffy, S.W. Easton, D.F. Eccles, D.M. Edwards, D.R. Edwards, J. Evans, D.G. Fenlon, D.F. Flanagan, J.M. Foster, C. Gallagher, W.M. Garcia-Closas, M. Gee, J.M. Gescher, A.J. Goh, V. Groves, A.M. Harvey, A.J. Harvie, M. Hennessy, B.T. Hiscox, S. Holen, I. Howell, S.J. Howell, A. Hubbard, G. Hulbert-Williams, N. Hunter, M.S. Jasani, B. Jones, L.J. Key, T.J. Kirwan, C.C. Kong, A. Kunkler, I.H. Langdon, S.P. Leach, M.O. Mann, D.J. Marshall, J.F. Martin, L.A. Martin, S.G. Macdougall, J.E. Miles, D.W. Miller, W.R. Morris, J.R. Moss, S.M. Mullan, P. Natrajan, R. O’Connor, J.P. O’Connor, R. Palmieri, C. Pharoah, P.D. Rakha, E.A. Reed, E. Robinson, S.P. Sahai, E. Saxton, J.M. Schmid, P. Smalley, M.J. Speirs, V. Stein, R. Stingl, J. Streuli, C.H. Tutt, A.N. Velikova, G. Walker, R.A. Watson, C.J. Williams, K.J. Young, L.S. Thompson, A.M. (2013). Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast cancer research, Vol.15 (5).

Beloueche-Babari, M. Jamin, Y. Arunan, V. Walker-Samuel, S. Revill, M. Smith, P.D. Halliday, J. Waterton, J.C. Barjat, H. Workman, P. Leach, M.O. Robinson, S.P. (2013). Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI. Br j cancer, Vol.109 (6), pp. 1562-1569.  show abstract

Boult, J.K. Terkelsen, J. Walker-Samuel, S. Bradley, D.P. Robinson, S.P. (2013). A multi-parametric imaging investigation of the response of C6 glioma xenografts to MLN0518 (tandutinib) treatment. Plos one, Vol.8 (4), p. e63024.  show abstract

Fryer, R.A. Graham, T.J. Smith, E.M. Walker-Samuel, S. Morgan, G.J. Robinson, S.P. Davies, F.E. (2013). Characterization of a novel mouse model of multiple myeloma and its use in preclinical therapeutic assessment. Plos one, Vol.8 (2), p. e57641.  show abstract

Boult, J.K. Jamin, Y. Jacobs, V. Gilmour, L.D. Walker-Samuel, S. Halliday, J. Elvin, P. Ryan, A.J. Waterton, J.C. Robinson, S.P. (2012). False-negative MRI biomarkers of tumour response to targeted cancer therapeutics. Br j cancer, Vol.106 (12), pp. 1960-1966.  show abstract

Baker, L.C. Boult, J.K. Walker-Samuel, S. Chung, Y.-. Jamin, Y. Ashcroft, M. Robinson, S.P. (2012). The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function. Br j cancer, Vol.106 (10), pp. 1638-1647.  show abstract

Burrell, J.S. Bradley, R.S. Walker-Samuel, S. Jamin, Y. Baker, L.C. Boult, J.K. Withers, P.J. Halliday, J. Waterton, J.C. Robinson, S.P. (2012). MRI measurements of vessel calibre in tumour xenografts: comparison with vascular corrosion casting. Microvasc res, Vol.84 (3), pp. 323-329.  show abstract

Bielen, A. Box, G. Perryman, L. Bjerke, L. Popov, S. Jamin, Y. Jury, A. Valenti, M. Brandon, A.D. Martins, V. Romanet, V. Jeay, S. Raynaud, F.I. Hofmann, F. Robinson, S.P. Eccles, S.A. Jones, C. (2012). Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition. Proc natl acad sci u s a, Vol.109 (20), pp. E1267-E1276.  show abstract

Walton, M.I. Eve, P.D. Hayes, A. Valenti, M.R. De Haven Brandon, A.K. Box, G. Hallsworth, A. Smith, E.L. Boxall, K.J. Lainchbury, M. Matthews, T.P. Jamin, Y. Robinson, S.P. Aherne, G.W. Reader, J.C. Chesler, L. Raynaud, F.I. Eccles, S.A. Collins, I. Garrett, M.D. (2012). CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs. Clin cancer res, Vol.18 (20), pp. 5650-5661.  show abstract

Burrell, J.S. Walker-Samuel, S. Baker, L.C. Boult, J.K. Jamin, Y. Ryan, A.J. Waterton, J.C. Halliday, J. Robinson, S.P. (2012). Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas. Int j cancer, Vol.131 (8), pp. 1854-1862.  show abstract

Walker-Samuel, S. Boult, J.K. McPhail, L.D. Box, G. Eccles, S.A. Robinson, S.P. (2012). Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts. Int j cancer, Vol.130 (6), pp. 1284-1293.  show abstract

Gillies, R.M. Robinson, S.P. McPhail, L.D. Carter, N.D. Murray, J.F. (2011). Immunohistochemical assessment of intrinsic and extrinsic markers of hypoxia in reproductive tissue: differential expression of HIF1 alpha and HIF2 alpha in rat oviduct and endometrium. Journal of molecular histology, Vol.42 (4), pp. 341-14.

Walker-Samuel, S. Orton, M. Boult, J.K. Robinson, S.P. (2011). Improving apparent diffusion coefficient estimates and elucidating tumor heterogeneity using Bayesian adaptive smoothing. Magn reson med, Vol.65 (2), pp. 438-447.  show abstract

Kostourou, V. Cartwright, J.E. Johnstone, A.P. Boult, J.K. Cullis, E.R. Whitley, G.S. Robinson, S.P. (2011). The role of tumour-derived iNOS in tumour progression and angiogenesis. British journal of cancer, Vol.104 (1), pp. 83-8.

Jamin, Y. Smyth, L. Robinson, S.P. Poon, E.S. Eykyn, T.R. Springer, C.J. Leach, M.O. Payne, G.S. (2011). Noninvasive detection of carboxypeptidase G2 activity in vivo. Nmr biomed, Vol.24 (4), pp. 343-350.  show abstract

Burrell, J.S. Walker-Samuel, S. Baker, L.C. Boult, J.K. Ryan, A.J. Waterton, J.C. Halliday, J. Robinson, S.P. (2011). Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging. Magn reson med, Vol.66 (1), pp. 227-234.  show abstract

Boult, J.K. Walker-Samuel, S. Jamin, Y. Leiper, J.M. Whitley, G.S. Robinson, S.P. (2011). Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. J pathol, Vol.225 (3), pp. 344-352.  show abstract

Faisal, A. Vaughan, L. Bavetsias, V. Sun, C. Atrash, B. Avery, S. Jamin, Y. Robinson, S.P. Workman, P. Blagg, J. Raynaud, F.I. Eccles, S.A. Chesler, L. Linardopoulos, S. (2011). The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. Mol cancer ther, Vol.10 (11), pp. 2115-2123.  show abstract

Chung, Y.-. Lin, G. Troy, H. Fong, A.-. Jackson, L.E. Hill, D.K. Orton, M. Koh, D.-. Robinson, S.P. Judson, I.R. Griffiths, J.R. Leach, M.O. Eykyn, T.R. (2011). Abstract 3788: Autophagy induced by DCA, PI3K inhibition or starvation results in reduced lactate production measured in real-time by DNP 13C MRS. Cellular and molecular biology, .

McPhail, L.D. Robinson, S.P. (2010). Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis. Radiology, Vol.254 (1), pp. 110-118.  show abstract

Walker-Samuel, S. Orton, M. McPhail, L.D. Boult, J.K. Box, G. Eccles, S.A. Robinson, S.P. (2010). Bayesian estimation of changes in transverse relaxation rates. Magn reson med, Vol.64 (3), pp. 914-921.  show abstract

Jamin, Y. Cullis, E.R. Vaughan, L. Koh, D.-. Chesler, L. Robinson, S.P. (2010). Abstract 4189: Characterization of tumor progression and chemoresponse in a novel transgenic mouse model of neuroblastoma (TH-MYCN) using magnetic resonance imaging. Tumor biology, .

Walker-Samuel, S. Orton, M. McPhail, L.D. Robinson, S.P. (2009). Robust estimation of the apparent diffusion coefficient (ADC) in heterogeneous solid tumors. Magn reson med, Vol.62 (2), pp. 420-429.  show abstract

Jamin, Y. Gabellieri, C. Smyth, L. Reynolds, S. Robinson, S.P. Springer, C.J. Leach, M.O. Payne, G.S. Eykyn, T.R. (2009). Hyperpolarized (13)C magnetic resonance detection of carboxypeptidase G2 activity. Magn reson med, Vol.62 (5), pp. 1300-1304.  show abstract

Robinson, S.P. Ludwig, C. Paulsson, J. Oestman, A. (2008). The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI. International journal of cancer, Vol.122 (7), pp. 1548-9.

Howe, F.A. McPhail, L.D. Griffiths, J.R. McIntyre, D.J. Robinson, S.P. (2008). Vessel size index magnetic resonance imaging to monitor the effect of antivascular treatment in a rodent tumor model. International journal of radiation oncology biology physics, Vol.71 (5), pp. 1470-7.

Madhu, B. Robinson, S.P. Howe, F.A. Griffiths, J.R. (2008). Effect of Gd-DTPA-BMA on Choline Signals of HT29 Tumors Detected by In Vivo H-1 MRS. Journal of magnetic resonance imaging, Vol.28 (5), pp. 1201-8.

Kalber, T.L. Waterton, J.C. Griffiths, J.R. Ryan, A.J. Robinson, S.P. (2008). Longitudinal In Vivo Susceptibility Contrast MRI Measurements of LS174T Colorectal Liver Metastasis in Nude Mice. Journal of magnetic resonance imaging, Vol.28 (6), pp. 1451-8.

Robinson, S.P. Howe, F.A. Griffiths, J.R. Ryan, A.J. Waterton, J.C. (2007). Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: A noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126. International journal of radiation oncology biology physics, Vol.69 (3), pp. 872-8.

Robinson, S. (2007). Identification of in vivo biomarkers of tumour response to vascular disrupting agents by magnetic resonance imaging and spectroscopy. Clinical oncology, Vol.19 (3), pp. S5-2.

McPhail, L.D. Griffiths, J.R. Robinson, S.P. (2007). Assessment of tumor response to the vascular disrupting agents 5,6-dimethylxanthenone-4-acetic acid or combretastatin-A4-phosphate by intrinsic susceptibility magnetic resonance imaging. Int j radiat oncol biol phys, Vol.69 (4), pp. 1238-1245.  show abstract

McPhail, L.D. McIntyre, D.J. Ludwig, C. Kestell, P. Griffiths, J.R. Kelland, L.R. Robinson, S.P. (2006). Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosis. Neoplasia, Vol.8 (3), pp. 199-8.

Cullis, E.R. Kalber, T.L. Ashton, S.E. Cartwright, J.E. Griffiths, J.R. Ryan, A.J. Robinson, S.P. (2006). Tumor overexpression of inducible nitric oxide synthase (NOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126. Microvascular research, Vol.71 (2), pp. 76-9.

Madhu, B. Waterton, J.C. Griffiths, J.R. Ryan, A.J. Robinson, S.P. (2006). The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy. Neoplasia, Vol.8 (7), pp. 560-567.  show abstract

Tatum, J.L. Kelloff, G.J. Gillies, R.J. Arbeit, J.M. Brown, J.M. Chao, K.S. Chapman, J.D. Eckelman, W.C. Fyles, A.W. Giaccia, A.J. Hill, R.P. Koch, C.J. Krishna, M.C. Krohn, K.A. Lewis, J.S. Mason, R.P. Melillo, G. Padhani, A.R. Powis, G. Rajendran, J.G. Reba, R. Robinson, S.P. Semenza, G.L. Swartz, H.M. Vaupel, P. Yang, D. Croft, B. Hoffman, J. Liu, G. Stone, H. Sullivan, D. (2006). Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int j radiat biol, Vol.82 (10), pp. 699-757.  show abstract

McSheehy, P.M. Port, R.E. Rodrigues, L.M. Robinson, S.P. Stubbs, M. van der Borns, K. Peters, G.J. Judson, I.R. Leach, M.O. Griffiths, J.R. (2005). Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours. Cancer chemotherapy and pharmacology, Vol.55 (2), pp. 117-12.

Dredge, K. Horsfall, R. Robinson, S.P. Zhang, L.H. Lu, L. Tang, Y. Shirley, M.A. Muller, G. Schafer, P. Stirling, D. Dalgleish, A.G. Bartlett, J.B. (2005). Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro. Microvascular research, Vol.69 (1-2), pp. 56-8.

Kalber, T.L. Smith, C.J. Howe, F.A. Griffiths, J.R. Ryan, A.J. Waterton, J.C. Robinson, S.P. (2005). A longitudinal study of R-2* and R-2 magnetic resonance imaging relaxation rate measurements in murine liver after a single administration of 3 different iron oxide-based contrast agents. Investigative radiology, Vol.40 (12), pp. 784-8.

Kelland, L.R. Baguley, B.C. Zhao, L. Kestell, P. McPhail, L.D. Robinson, S.P. Ravic, M. Jameson, M.B. McKeage, M.J. (2005). Mouse, rat and clinical studies with the tumour vascular disrupting agent (VDA) 5,6 dimethyl xanthenone acetic acid, DMXAA: 5-hydroxyindole-3-acetic acid (5HIAA) plasma levels as a pharmacodynamic marker of blood flow changes. Ejc supplements, Vol.3 (2), pp. 421-2.

Robinson, S.P. Kalber, T.L. Howe, F.A. McIntyre, D.J. Griffiths, J.R. Blakey, D.C. Whittaker, L. Ryan, A.J. Waterton, J.C. (2005). Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging. Neoplasia, Vol.7 (5), pp. 466-474.  show abstract

McPhail, L.D. Chung, Y.L. Madhu, B. Clark, S. Griffiths, J.R. Kelland, L.R. Robinson, S.P. (2005). Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy. Clinical cancer research, Vol.11 (10), pp. 3705-9.

McPhail, L.D. Chung, Y.L. Madhu, B. Clark, S. Griffiths, J.R. Kelland, L.R. Robinson, S.P. (2005). Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy. , Vol.11, pp. 3705-3713.  show abstract

Howe, F.A. Connelly, J.P. Robinson, S.P. Springett, R. Griffiths, J.R. (2005). The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS. Adv exp med biol, Vol.566, pp. 75-81.  show abstract

Nöth, U. Rodrigues, L.M. Robinson, S.P. Jork, A. Zimmermann, U. Newell, B. Griffiths, J.R. (2004). In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors. Int j radiat oncol biol phys, Vol.60 (3), pp. 909-919.  show abstract

McIntyre, D.J. Robinson, S.P. Howe, F.A. Griffiths, J.R. Ryan, A.J. Blakey, D.C. Peers, I.S. Waterton, J.C. (2004). Single dose of the antivascular agent, ZD6126 (N-acetylcoichinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model. Neoplasia, Vol.6 (2), pp. 150-8.

Rodrigues, L.M. Stubbs, M. Robinson, S.P. Newell, B. Mansi, J. Griffiths, J.R. (2004). The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods. Magnetic resonance materials in physics biology and medicine, Vol.17 (3-6), pp. 260-11.

Rodrigues, L.M. Howe, F.A. Griffiths, J.R. Robinson, S.P. (2004). Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors. J magn reson imaging, Vol.19 (4), pp. 482-488.  show abstract

Kostourou, V. Troy, H. Murray, J.F. Cullis, E.R. Whitley, G.S. Griffiths, J.R. Robinson, S.P. (2004). Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo. Neoplasia, Vol.6 (4), pp. 401-411.  show abstract

Robinson, S.P. Griffiths, J.R. (2004). Current issues in the utility of F-19 nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. Philosophical transactions of the royal society of london series b-biological sciences, Vol.359 (1446), pp. 987-10.

Robinson, S.P. Rijken, P.F. Howe, F.A. McSheehy, P.M. van der Sanden, B.P. Heerschap, A. Stubbs, M. van der Kogel, A.J. Griffiths, J.R. (2003). Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J magn reson imaging, Vol.17 (4), pp. 445-454.  show abstract

Kostourou, V. Robinson, S.P. Whitley, G.S. Griffiths, J.R. (2003). Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer res, Vol.63 (16), pp. 4960-4966.  show abstract

Robinson, S.P. McIntyre, D.J. Checkley, D. Tessier, J.J. Howe, F.A. Griffiths, J.R. Ashton, S.E. Ryan, A.J. Blakey, D.C. Waterton, J.C. (2003). Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br j cancer, Vol.88 (10), pp. 1592-1597.  show abstract

Howe, F.A. Robinson, S.P. Rodrigues, L.M. Stubbs, M. Griffiths, J.R. (2003). Issues in GRE & SE magnetic resonance imaging to probe tumor oxygenation. Adv exp med biol, Vol.530, pp. 441-448.  show abstract

Griffiths, J.R. McSheehy, P.M. Robinson, S.P. Troy, H. Chung, Y.L. Leek, R.D. Williams, K.J. Stratford, I.J. Harris, A.L. Stubbs, M. (2002). Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1 beta (HIF-1 beta): Evidence of an anabolic role for the HIF-1 pathway. Cancer research, Vol.62 (3), pp. 688-8.

Kostourou, V. Robinson, S.P. Cartwright, J.E. Whitley, G.S. (2002). Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis. British journal of cancer, Vol.87 (6), pp. 673-8.

Rodrigues, L.M. Robinson, S.P. McSheehy, P.M. Stubbs, M. Griffiths, J.R. (2002). Enhanced uptake of ifosfamide into GH3 prolactinomas with hypercapnic hyperoxic gases monitored in vivo by (31)P MRS. Neoplasia, Vol.4 (6), pp. 539-543.  show abstract

Stubbs, M. Robinson, S.P. Hui, C. Price, N.M. Rodrigues, L.M. Howe, F.A. Griffiths, J.R. (2002). The importance of tumor metabolism in cancer prognosis and therapy; pre-clinical studies on rodent tumors with agents that improve tumor oxygenation. Adv enzyme regul, Vol.42, pp. 131-141.

McIntyre, D.J. Robinson, S.P. Tessier, J.J. Checkley, D. Howe, F.A. Griffiths, J.R. Blakey, D.C. Waterton, J.C. (2001). Tumor dose response to the novel vascular targeting agent ZD6126 assessed by dynamic contrast-enhanced MRI. Clinical cancer research, Vol.7 (11), pp. 3653S-1.

Robinson, S.P. Rodrigues, L.M. Howe, F.A. Stubbs, M. Griffiths, J.R. (2001). Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases. Magn reson imaging, Vol.19 (2), pp. 161-166.  show abstract

Howe, F.A. Robinson, S.P. McIntyre, D.J. Stubbs, M. Griffiths, J.R. (2001). Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. Nmr biomed, Vol.14 (7-8), pp. 497-506.  show abstract

Gillies, R.J. Bhujwalla, Z.M. Evelhoch, J. Garwood, M. Neeman, M. Robinson, S.P. Sotak, C.H. Van Der Sanden, B. (2000). Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia, Vol.2 (1-2), pp. 139-151.  show abstract

Robinson, S.P. Howe, F.A. Stubbs, M. Griffiths, J.R. (2000). Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels. British journal of cancer, Vol.82 (12), pp. 2007-8.

Robinson, S.P. Collingridge, D.R. Howe, F.A. Rodrigues, L.M. Chaplin, D.J. Griffiths, J.R. (1999). Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. Nmr in biomedicine, Vol.12 (2), pp. 98-9.

Griffiths, J.R. Robinson, S.P. (1999). The OxyLite: a fibre-optic oxygen sensor. Br j radiol, Vol.72 (859), pp. 627-630.

Howe, F.A. Robinson, S.P. Rodrigues, L.M. Griffiths, J.R. (1999). Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magn reson imaging, Vol.17 (9), pp. 1307-1318.  show abstract

Robinson, S.P. Rodrigues, L.M. Griffiths, J.R. Stubbs, M. (1999). Response of hepatoma 9618a and normal liver to host carbogen and carbon monoxide breathing. Neoplasia, Vol.1 (6), pp. 537-543.  show abstract

Robinson, S.P. van den Boogaart, A. Maxwell, R.J. Griffiths, J.R. Hamilton, E. Waterton, J.C. (1998). P-31-magnetic resonance spectroscopy and H-2-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models. British journal of cancer, Vol.77 (11), pp. 1752-9.

Robinson, S.P. Howe, F.A. Rodrigues, L.M. Stubbs, M. Griffiths, J.R. (1998). Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. Seminars in radiation oncology, Vol.8 (3), pp. 197-11.

Stubbs, M. Robinson, S.P. Rodrigues, L.M. Parkins, C.S. Collingridge, D.R. Griffiths, J.R. (1998). The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a. Br j cancer, Vol.78 (11), pp. 1449-1456.  show abstract

McSheehy, P.M. Robinson, S.P. Ojugo, A.S. Aboagye, E.O. Cannell, M.B. Leach, M.O. Judson, I.R. Griffiths, J.R. (1998). Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: A magnetic resonance study in vivo. Cancer research, Vol.58 (6), pp. 1185-10.

Rodrigues, L.M. Maxwell, R.J. McSheehy, P.M. Pinkerton, C.R. Robinson, S.P. Stubbs, M. Griffiths, J.R. (1997). In vivo detection of ifosfamide by P-31-MRS in rat tumours: Increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. British journal of cancer, Vol.75 (1), pp. 62-7.

Robinson, S.P. Barton, S.J. McSheehy, P.M. Griffiths, J.R. (1997). Nuclear magnetic resonance spectroscopy of cancer. British journal of radiology, Vol.70, pp. S60-10.

Griffiths, J.R. Taylor, N.J. Howe, F.A. Saunders, M.I. Robinson, S.P. Hoskin, P.J. Powell, M.E. Thoumine, M. Caine, L.A. Baddeley, H. (1997). The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging. International journal of radiation oncology biology physics, Vol.39 (3), pp. 697-5.

Robinson, S.P. Rodrigues, L.M. Ojugo, A.S. McSheehy, P.M. Howe, F.A. Griffiths, J.R. (1997). The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. British journal of cancer, Vol.75 (7), pp. 1000-7.

Stubbs, M. Robinson, S.P. Rodrigues, L.R. Griffiths, J.R. (1996). The effect of carbogen breathing on intra- and extracellular pH and [lactate] in rat hepatomas. British journal of cancer, Vol.73 (8), pp. 15-1.

McCoy, C.L. McIntyre, D.J. Robinson, S.P. Aboagye, E.O. Griffiths, J.R. (1996). Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation. Br j cancer suppl, Vol.27, pp. S226-S231.  show abstract

Howe, F.A. Robinson, S.P. Griffiths, J.R. (1996). Modification of tumour perfusion and oxygenation monitored by gradient recalled echo MRI and 31P MRS. Nmr biomed, Vol.9 (5), pp. 208-216.  show abstract

ROBINSON, S.P. HOWE, F.A. GRIFFITHS, J.R. (1995). NONINVASIVE MONITORING OF CARBOGEN-INDUCED CHANGES IN TUMOR BLOOD-FLOW AND OXYGENATION BY FUNCTIONAL MAGNETIC-RESONANCE-IMAGING. International journal of radiation oncology biology physics, Vol.33 (4), pp. 855-5.

HOWELLS, S.L. MAXWELL, R.J. HOWE, F.A. PEET, A.C. STUBBS, M. RODRIGUES, L.M. ROBINSON, S.P. BALUCH, S. GRIFFITHS, J.R. (1993). PATTERN-RECOGNITION OF P-31 MAGNETIC-RESONANCE SPECTROSCOPY TUMOR SPECTRA OBTAINED IN-VIVO. Nmr in biomedicine, Vol.6 (4), pp. 237-5.

Robinson, S.P. Reid, D.G. Gajjar, K. Hickey, D.M. Benson, G.M. Haynes, C. Leeson, P.D. Whittaker, C.M. (1991). Precipitation and 13C-NMR relaxation enhancement measurements of the interactions of bile acids with synthetic cationic bile acid derivatives, and with spin labelled fatty acids. Chemistry and physics of lipids, Vol.60, pp. 143-151.

Reid, D.G. MacLachlan, L.K. Robinson, S.P. Camilleri, P. Dyke, C.A. Thorpe, C.J. (1990). Calmodulin discriminates between the two enantiomers of the receptor-operated calcium channel blocker SK&F 96365: a study using 1H-NMR and chiral HPLC. Chirality, Vol.2 (4), pp. 229-232.  show abstract

Berry, T. Luther, W. Bhatnager, N. Jamin, Y. Poon, E. Sanda, T. Pei, D. Sharma, B. Vetharoy, W.R. Hallsworth, A. Ahmad, Z. Barker, K. Moreau, L. Webber, H. Wang, W. Liu, Q. Perez-Atayde, A. Rodig, S. Cheung, N.K. Raynaud, F. Hallberg, B. Robinson, S.P. Gray, N.S. Pearson, A.D. Eccles, S.A. George, R.E. Chesler, L. The ALK(F1174L) Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma. Cancer cell, Vol.22 (1), pp. 117-130.

Hill, D.K. Ortom, M.R. Mariotti, E. Boult, J.K. Panek, R. Jafar, M. Parkes, H.G. Jamin, Y. Miniotis, M.F. Al-Saffar, M.S. Beloueche-Babari, M. Robinson, S.P. Leach, M.O. Chung, Y.-. Eykyn, T.R. Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized 13C Magnetic Resonance Spectroscopy Data. Plos one, Vol.9 (8).  show abstract

Poon, E. Jamin, Y. Liang, T. Waltz, S. Kwok, C. Hakkert, A. Richards, M. Urban, Z. Thway, K. Zied, R. Box, G. Ebus, M. Barker, K. Licciardello, M. Sbirkov, Y. Lazaro, G. Danielson, L. Tardif, N. Almeida, G. Christova, R. Boysen, G. Ford, A. Clarke, P. De Bono, J. Robinson, S. Eccles, S. Zheleva, D. Workman, P. Bradner, J. Molenaar, J. Vivanco, I. Bayliss, R. Eilers, M. Lin, C. Chesler, L. Pharmacological blockade of MYCN in neuroblastoma using orally-bioavailable CDK inhibitors reveals an approach widely applicable to Myc-dependent cancers. Nature medicine, .  show abstract

Hill, D.L. Eriksson, E.M. Li Wai Suen, C.S. Chiu, C.Y. Ryg-Cornejo, V. Robinson, L.J. Siba, P.M. Mueller, I. Hansen, D.S. Schofield, L. Opsonising Antibodies to P falciparum Merozoites Associated with Immunity to Clinical Malaria. Plos one, Vol.8 (9), pp. e74627-e74627.


Book Chapters

Robinson, S.P. McPhail, L.D. (2010). Lessons from animal imaging in preclinical models. In Meyer, T. (Ed.), Vascular Disruptive Agents for the Treatment of Cancer. (pp. 95-256). Springer Verlag, ISBN: 9781441966087.

Robinson, S.P. (2006). BOLD imaging of tumors. In Padhani, A.R.Choyke, P.L. (Eds.), New techniques in oncologic imaging. (pp. 257-377). Informa HealthCare, ISBN: 9780849392740.

Robinson, S.P. McCoy, C.L. Griffiths, J.R. (2000). Spectroscopic studies of animal tumor models. Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy. (pp. 914-919). John Wiley & Sons.

Robinson, S.P. McCoy, C.L. Griffiths, J.R. (1996). Spectroscopic studies of animal tumor models. In Grant, D.M.Harris, R.K. (Eds.), The Encyclopaedia of Nuclear Magnetic Resonance. (pp. 828-828). John Wiley & Sons.


Conferences

Li, J.Boult, J.K.Vinci, M.Popov, S.Barker, K.Ahmad, Z.Jamin, Y.Cummings, C.Eccles, S.A.Bamber, J.C.Sinkus, R.Chesler, L.Jones, C.Robinson, S.P. (2015). Abstract 1488: In vivo magnetic resonance elastography in pediatric brain tumor models, Cancer Research, Vol.75 (15_Supplement), p.1488.

Papaevangelou, E.Almeida, G.S.Jamin, Y.Robinson, S.P.deSouza, N.M. (2015). Abstract 2930: Differential tumour response to birinapant and irinotecan revealed by non-invasive MRI, Cancer Research, Vol.75 (15_Supplement), p.2930.

Almeida, G.S.King, P.Jamin, Y.Hallsworth, A.Webber, H.Popov, S.Pearson, A.D.Chesler, L.Robinson, S.P. (2015). Abstract 491: Tumor response to cabozantinib in the TH-MYCN GEM model of neuroblastoma, Cancer Research, Vol.75 (15_Supplement), p.491.

Boult, J.K.Taylor, K.R.Vinci, M.Popov, S.Jury, A.Molinari, V.Alonso, M.M.Ingram, W.Caraboso, A.M.Monje, M.Eccles, S.A.Jones, C.Robinson, S.P. (2015). Abstract 3271: Novel orthotopic pediatric high grade glioma xenografts evaluated with magnetic resonance imaging mimic human disease, Cancer Research, Vol.75 (15_Supplement), p.3271.

Robinson, S.P. (2015). Abstract 1372: Acquired resistance to sunitinib is not associated with functional re-vascularization in 786-O renal cell carcinoma xenografts, Cancer Research, Vol.75 (15_Supplement), p.1372.

Hill, R.M.Kuijper, S.Lindsey, J.Schwalbe, E.C.Barker, K.Boult, J.Williamson, D.Ahmad, Z.Hallsworth, A.Ryan, S.Poon, E.Robinson, S.Ruddle, R.Raynaud, F.Howell, L.Kwok, C.Joshi, A.Nicholson, S.Crosier, S.Wharton, S.Jacques, T.Robson, K.Michalski, A.Hargrave, D.Pizer, B.Bailey, S.Swartling, F.J.Petrie, K.Weiss, W.A.Chesler, L.Clifford, S. (2014). Abstract LB-201: MYC and TP53 defects interact at medulloblastoma relapse to define rapidly progressive disease and can be targeted therapeutically, Cancer Research, Vol.74 (19_Supplement).

Boult, J.Li, J.Vinci, M.Jury, A.Popov, S.Jamin, Y.Cummings, C.Eccles, S.Bamber, J.Sinkus, R.Jones, C.Robinson, S. (2014). IMAGING THE TENSIONAL HOMEOSTASIS OF ORTHOTOPIC PAEDIATRIC GLIOMA XENOGRAFTS IN VIVO WITH MAGNETIC RESONANCE ELASTOGRAPHY, NEURO-ONCOLOGY, Vol.16, pp.48-49.

Boult, J.Vinci, M.Taylor, K.Perryman, L.Box, G.Jury, A.Popov, S.Ingram, W.Monje, M.Eccles, S.Jones, C.Robinson, S. (2014). NOVEL ORTHOTOPIC PAEDIATRIC GLIOBLASTOMA XENOGRAFTS EVALUATED WITH MAGNETIC RESONANCE IMAGING MIMIC HUMAN DISEASE, NEURO-ONCOLOGY, Vol.16, p.48.

Hill, R.Kuijper, S.Lindsey, J.Schwalbe, E.Barker, K.Boult, J.Williamson, D.Ahmad, Z.Hallsworth, A.Ryan, S.Poon, E.Robinson, S.Ruddle, R.Raynaud, F.Howell, L.Kwok, C.Joshi, A.Nicholson, S.L.Crosier, S.Wharton, S.Robson, K.Michalski, A.Hargrave, D.Jacques, T.Pizer, B.Bailey, S.Swartling, F.Petrie, K.Weiss, W.Chesler, L.Clifford, S. (2014). MYC AND TP53 DEFECTS EMERGE AND INTERACT AT MEDULLOBLASTOMA RELAPSE, DEFINE RAPIDLY PROGRESSIVE DISEASE AND CAN BE TARGETED THERAPEUTICALLY, NEURO-ONCOLOGY, Vol.16, p.74.

Price, J.M.Baker, L.C.Boult, J.K.Box, C.Kramer-Marek, G.Murray, I.Robinson, S.P.Leach, M.O. (2014). 18F-fluorodeoxyglucose (FDG) uptake is increased in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistant compared with sensitive head and neck cancer xenografts, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Vol.41, p.S638.

Shah, A.J.Alles, E.J.Box, C.Eccles, S.A.Robinson, S.P.deSouza, N.Bamber, J.C. (2014). Non-invasive molecular profiling of cancer using photoacoustic imaging of functionalized gold nanorods, PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2014, Vol.8943.

Box, C.Baker, L.C.Beloueche-Babari, M.Rogers, S.J.Box, G.M.Harrington, K.J.Leach, M.O.Robinson, S.P.Eccles, S.A. (2013). 2D, 3D and in vivo models of head and neck cancer identify novel correlates of resistance to epidermal growth factor receptor tyrosine kinase inhibitors, EUROPEAN JOURNAL OF CANCER, Vol.49, p.S772.

Baker, L.C.Box, C.Sikka, A.Box, G.Eccles, S.A.Robinson, S.P. (2013). Evaluating imaging biomarkers of acquired resistance to targeted EGFR therapy in xenograft models of human squamous cell carcinoma of the head and neck (SCCHN)., CANCER RESEARCH, Vol.73 (8).

Boult, J.K.Jury, A.Popov, S.Perryman, L.Box, G.Jones, C.Eccles, S.A.Robinson, S.P. (2013). Evaluation of MR imaging biomarkers of the vascular and infiltrative phenotype in intracranial MDA-MB-231 tumors, CANCER RESEARCH, Vol.73 (8).

Jamin, Y.Glass, L.Hallsworth, A.George, R.E.Koh, D.-.Pearson, A.D.Chesler, L.Robinson, S.P. (2013). Intrinsic susceptibility magnetic resonance imaging identifies tumors with ALKF1174L mutation in transgenic murine models of high-risk neuroblastoma., CANCER RESEARCH, Vol.73 (8).

Beloueche-Babari, M.Jamin, Y.Walker-Samuel, S.Smith, P.D.Waterton, J.C.Halliday, J.Barjat, H.Workman, P.Leach, M.O.Robinson, S.P. (2012). Non-invasive Imaging of Response to MEK Inhibition With Selumetinib (AZD6244, ARRY-142886) in a Human Colorectal Cancer Xenograft Using Diffusion-Weighted MRI, EUROPEAN JOURNAL OF CANCER, Vol.48, p.S202.

Elyas, E.Erler, J.Robinson, S.P.Cox, T.Woods, D.Clowes, P.Bamber, J.C.IEEE, (2012). Potential for quantitative microelastography using a multi-channel optical coherence method, 2012 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), , pp.2567-2570.

Baker, L.C.Chung, Y.-.Boult, J.K.Ashcroft, M.A.Robinson, S.P. (2011). The effects of the HIF pathway inhibitor NSC-134754 on glucose metabolism, CANCER RESEARCH, Vol.71.

Baker, L.C.Chung, Y.-.Boult, J.K.Ashcroft, M.A.Robinson, S.P. (2011). Abstract 4074: The effects of the HIF pathway inhibitor NSC-134754 on glucose metabolism, Presented at Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL, Cellular and Molecular Biology, .

Jamin, Y.Cullis, E.R.Vaughan, L.Webber, H.Boult, J.K.Baker, L.C.Dow-Mu, K.Chesler, L.Robinson, S.P. (2011). Abstract 5290: Imaging biomarkers of response to chemotherapy in neuroblastoma, Cancer Research, Vol.71 (8_Supplement), p.5290.

Fryer, R.A.Graham, T.J.Smith, E.M.Walker, B.A.Morgan, G.J.Robinson, S.P.Davies, F.E. (2011). A Novel Mouse Model of Multiple Myeloma Representative of Human Disease and Its Use in Preclinical Therapeutic Assessment, BLOOD, Vol.118 (21), pp.1253-1254.

Perryman, L.A.Box, G.Boult, J.K.Marshall, L.Popoy, S.Jury, A.Pearson, A.D.Workman, P.Hargrave, D.Robinson, S.P.Jones, C.Eccles, S.A. (2010). DEVELOPMENT AND CHARACTERISATION OF IN VIVO MODELS OF PAEDIATRIC HIGH-GRADE GLIOMA, Presented at 14th International Symposium on Pediatric Neuro-Oncology, Vienna, AUSTRIA. NEURO-ONCOLOGY, Vol.12 (6), pp.II49-2.

Walker-Samuel, S.Boult, J.McPhail, L.Box, G.Eccles, S.Robinson, S. (2009). Non-invasive assessment of tumor vessel size in orthotopic prostate tumors and response to the vascular disrupting agent ZD6126, CANCER RESEARCH, Vol.69.

Boult, J.Walker-Samuel, S.Leiper, J.Whitley, G.Robinson, S. (2009). Effect of active site mutant DDAH1 in C6 glioma xenografts, CANCER RESEARCH, Vol.69.

Boult, J.K.Robinson, S.P.Walker-Samuel, S.Bradley, D.P. (2009). CHRONIC DOSING WITH MLN0518 (TANDUTINIB), A SMALL MOLECULE PDGFR ALPHA/BETA INHIBITOR, REDUCES TUMOR HYPOXIA AND PERFUSION IN C6 GLIOMA XENOGRAFTS, NEURO-ONCOLOGY, Vol.11 (5), p.588.

Boult, J.K.Walker-Samuel, S.Bradley, D.P.Robinson, S.P. (2009). Abstract B257: Chronic dosing with MLN0518 (Tandutinib), a small molecule PDGFRα/β inhibitor, reduces tumor growth, hypoxia, and perfusion in C6 glioma xenografts: An investigation using immunohistochemical and MRI methods, Molecular Cancer Therapeutics, Vol.8 (12_Supplement), p.B257.

Baker, L.C.Boult, J.K.Walker-Samuel, S.Jamin, Y.Ashcroft, M.A.Robinson, S.P. (2009). Abstract C90: An MRI and histological investigation of the acute response of orthotopic PC3 prostate tumors to the HIF pathway inhibitor NSC-134754 in vivo, Molecular Cancer Therapeutics, Vol.8 (12_Supplement), p.C90.

Ostman, A.Pietras, K.Hagerstrand, D.Furuhashi, M.Abe, M.Robinson, S.Wu, Y.Hicklin, D.J.Baranowska-Kortylewicz, J.Nister, M.Heldin, C.H.Rubin, K. (2005). PDGF receptors as cancer drug targets, Presented at 3rd International Symposium on Targeted Anticancer Therapies, Amsterdam, NETHERLANDS. ANNALS OF ONCOLOGY, Vol.16, pp.21-1.

Robinson, S.P.Ludwig, C.Paulsson, J.Ostman, A. (2005). The role of platelet-derived growth factor on tumour vascular function and morphology in vivo assessed by susceptibility magnetic resonance imaging., Presented at AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, Philadelphia, PA. CLINICAL CANCER RESEARCH, Vol.11 (24), pp.9128S-1.

McPhail, L.D.Chung, Y.L.Madhu, B.Clark, S.Griffiths, J.R.Kelland, L.R.Robinson, S.P. (2004). Tumour dose response to 5,6-dimethylxanthenone-4-acetic acid (DMXAA) assessed by in vivo magnetic resonance spectroscopy, Presented at British Cancer Research Meeting 2004, Manchester, ENGLAND. BRITISH JOURNAL OF CANCER, Vol.91, pp.S45-1.

Kalber, T.L.Robinson, S.P.Howe, F.A.Ryan, A.J.Waterton, J.C.Griffiths, J.R. (2004). In vivo susceptibility contrast MRI of murine models of liver metastasis, Presented at British Cancer Research Meeting 2004, Manchester, ENGLAND. BRITISH JOURNAL OF CANCER, Vol.91, pp.S46-1.

Robinson, S.P.Kalber, T.L.Howe, F.A.McIntyre, D.J.Griffiths, J.R.Blakey, D.C.Whittaker, L.Ryan, A.J.Waterton, J.C. (2004). Use of intrinsic-susceptibility magnetic resonance imaging to assess acute tumor response to the vascular-targeting agent ZD6126, Presented at British Cancer Research Meeting 2004, Manchester, ENGLAND. BRITISH JOURNAL OF CANCER, Vol.91, pp.S46-1.

Robinson, S.P.Kostourou, V.Troy, H.Murray, J.F.Whitley, G.Griffiths, J.R. (2003). Overexpression of dimethylarginine dimethylaminohydrolase (ddah) enhances turnout growth, angiogenesis and hypoxia., Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, BOSTON, MASSACHUSETTS. CLINICAL CANCER RESEARCH, Vol.9 (16), pp.6209S-1.

McIntyre, D.J.Robinson, S.P.Howe, F.A.Griffiths, J.R.Ryan, A.J.Blakey, D.C.Peers, I.S.Waterton, J.C. (2002). Absence of vascular regrowth at 96hrs in response to the vascular-targeting agent ZD6126 demonstrated by dynamic-contrast enhanced (DCE) MRI, Presented at 14th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics, FRANKFURT, GERMANY. EUROPEAN JOURNAL OF CANCER, Vol.38, pp.S37-1.

GRIFFITHS, J.R.MAXWELL, R.J.HOWELLS, S.L.HOWE, F.A.ROBINSON, S.P.STUBBS, M.MCCOY, C.L.RODRIGUES, L.M.PARKINS, C.L.CHAPLIN, D.J. (1994). MRS STUDIES OF CANCER, Presented at 1st Nottingham Symposium on Magnetic Resonance Imaging, NOTTINGHAM, ENGLAND. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, Vol.2 (3), pp.253-5.